We are upgrading our infrastructure for a faster experience. We appreciate your patience in the meantime.
What is PEP? PEP, or Post-Exposure Prophylaxis, refers to a short-term regimen of medication – most commonly antiretroviral therapy, administered after possible exposure to HIV to reduce the risk of infection. It must be initiated within 72 hours, with earlier administration being more effective. Why is PEP Critical in HIV Prevention? HIV can establish infection rapidly, often within 24 […]
Post-Exposure Prophylaxis (PEP) Read More »
What is Post-Market Surveillance (PMS)? Post-Market Surveillance (PMS) refers to the continuous monitoring and evaluation of pharmaceutical products, medical devices, or APIs after they have been released into the market. It involves systematically collecting, analyzing, and interpreting data on product performance, adverse effects, and safety signals to ensure ongoing compliance with Good Pharmacovigilance Practices (GVP) and regulatory standards. PMS is a
Post-Market Surveillance (PMS) Read More »
